Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

M Raikou, A McGuire, H M Colhoun, D J Betteridge, P N Durrington, G A Hitman, H A W Neil, S J Livingstone, V Charlton-Menys, J H Fuller, CARDS Investigators

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)

    Abstract

    We estimated the cost-effectiveness of atorvastatin treatment in the primary prevention of cardiovascular disease in patients with type 2 diabetes using data from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Original languageEnglish
    Pages (from-to)733-740
    Number of pages8
    JournalDiabetologia
    Volume50
    Issue number4
    DOIs
    Publication statusPublished - 2007

    Fingerprint Dive into the research topics of 'Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)'. Together they form a unique fingerprint.

    Cite this